Just a moment, the page is loading...

Ethicon & Auris

Research Opportunities

Posting
Clinical outcomes associated with the use ETHIZIA™ Hemostatic Sealing Patch for soft tissue bleeding during cardiovascular surgical procedures (EMEA/AsiaPac).
ETHICON, Inc. is interested in receiving proposals investigating ETHIZIA™ Hemostatic Sealing Patch (herein ETHIZIA) when used as an adjunct to control bleeding from soft tissue during open or minimally invasive cardiovascular surgical procedures.
Posting
Clinical outcomes associated with the use ETHIZIA™ Hemostatic Sealing Patch to achieve hemostasis during open or minimally invasive surgery (EMEA/AsiaPac)
ETHICON, Inc. is interested in receiving proposals investigating the use of the ETHIZIA™ Hemostatic Sealing Patch (herein ETHIZIA) when used as an adjunct to control bleeding during open or minimally invasive surgeries. Use of ETHIZIA on cardiovascular or neurological tissue is excluded.
Posting
Clinical or Utilization Outcomes Associated with the use of the MONARCH™ Platform in Diagnostic or Therapeutic Bronchoscopy
Johnson and Johnson MedTech Surgery, is interested in receiving proposals for investigating the clinical usage of the MONARCH™ Platform and outcomes in diagnostic or therapeutic bronchoscopy when used as indicated.
Posting
Clinical outcomes associated with the use STRATAFIX™ Spiral PDS™ Plus Unidirectional/Bidirectional for soft tissue approximation in cardio-thoracic, orthopedic (including joint/spine), general surgery and OB-GYN procedures
ETHICON, Inc. is interested in receiving proposals for investigating the use of the STRATAFIX™ Knotless Tissue Control Device for use in soft tissue approximation where the use of absorbable sutures is appropriate.
Posting
Funding opportunity for research involving the use of Megadyne products.
ETHICON, Inc. is interested in receiving proposals for research involving Megadyne products.

Visit our Family of Companies

  • Biosense-Webster
  • Cerenovus
  • Mentor
  • Acclarent
  • Ethicon
  • Auris
  • Depuy